AAAAAA
Results:
1-10
|
Results: 10
Authors:
YU W
KEILANI T
FEHMI H
SCHLUETER W
BATLLE D
Citation: W. Yu et al., A DOUBLE-BLIND COMPARATIVE-STUDY OF 2 ANGIOTENSIN-II CONVERTING-ENZYME INHIBITORS (ACEI) ON ALDOSTERONE (A) AND POTASSIUM, Journal of the American Society of Nephrology, 7(9), 1996, pp. 546-546
Authors:
KEILANI T
SCHLUETER W
FEHMI H
ESPARAZ D
ROSA R
ROBERTSON G
BATLLE D
Citation: T. Keilani et al., ARGININE-VASOPRESSIN (AVP) SECRETION DURING POTASSIUM (K) DEPLETION IN NORMAL SUBJECTS, Journal of the American Society of Nephrology, 6(3), 1995, pp. 440-440
Authors:
KAPLAN B
WANG Z
KEILANI T
KAUFMAN DB
Citation: B. Kaplan et al., THE SPECIFICITY OF MONOCLONAL FLUORESCENCE POLARIZATION IMMUNOASSAY FOR CYCLOSPORINE IN RECIPIENTS OF SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTS, Therapeutic drug monitoring, 17(5), 1995, pp. 499-503
Authors:
CONNOR J
KEILANI T
SEGAL R
WINCHELL G
TANAKA W
SWITHENBANK R
LEVINE B
BATLLE D
Citation: J. Connor et al., PHARMACOKINETICS AND SAFETY OF DORZOLAMIDE (MK-507) IN PATIENTS WITH MODERATE RENAL IMPAIRMENT, Investigative ophthalmology & visual science, 36(4), 1995, pp. 738-738
Authors:
KEILANI T
SCHLUETER W
BATLLE D
Citation: T. Keilani et al., SELECTED ASPECTS OF ACE-INHIBITOR THERAPY FOR PATIENTS WITH RENAL-DISEASE - IMPACT ON PROTEINURIA, LIPIDS AND POTASSIUM, Journal of clinical pharmacology, 35(1), 1995, pp. 87-97
Authors:
KAPLAN B
KAUFMAN DB
KEILANI T
WANG Z
Citation: B. Kaplan et al., DIFFERENTIAL SPECIFICITY OF MONOCLONAL FPIA CYCLOSPORINE (CSA) LEVELSIN RECIPIENTS OF COMBINED KIDNEY-PANCREAS VS KIDNEY ALONE TRANSPLANTS, Clinical research, 42(3), 1994, pp. 10000413-10000413
Authors:
KEILANI T
SCHLUETER WA
KAPLAN B
MOLTENI A
BATLLE DC
Citation: T. Keilani et al., THERAPEUTIC ADVANTAGE OF LOW-DOSE ANGIOTENSIN-CONVERTING ENZYME (ACE)INHIBITION FOR PATIENTS WITH PROTEINURIA AND RENAL IMPAIRMENT, Clinical research, 42(2), 1994, pp. 10000222-10000222
Authors:
SCHLUETER W
KEILANI T
BATLLE DC
Citation: W. Schlueter et al., TISSUE RENIN-ANGIOTENSIN SYSTEMS - THEORETICAL IMPLICATIONS FOR THE DEVELOPMENT OF HYPERKALEMIA USING ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS, The American journal of the medical sciences, 307, 1994, pp. 190000081-190000086
Authors:
KEILANI T
SCHLUETER W
BATLLE D
Citation: T. Keilani et al., ANGIOTENSIN-CONVERTING-ENZYME INHIBITORS AND CHYLURIA - RESPONSE, Annals of internal medicine, 119(12), 1993, pp. 1224-1224
Authors:
SCHLUETER W
KEILANI T
BATLLE DC
Citation: W. Schlueter et al., METABOLIC EFFECTS OF CONVERTING-ENZYME INHIBITORS - FOCUS ON THE REDUCTION OF CHOLESTEROL AND LIPOPROTEIN(A) BY FOSINOPRIL, The American journal of cardiology, 72(20), 1993, pp. 80000037-80000044
Risultati:
1-10
|